Frontrunners in Molecular Glues.
In: Pharmaceutical Technology Europe, Jg. 36 (2024), Heft 1, S. 18-20
serialPeriodical
Zugriff:
The article focuses on the development of molecular glues for targeted protein degradation, with companies like Orionis Biosciences leading the field. Topics include the use of molecular glues in cancer treatment, partnerships between biopharma companies, and competition from Chinese and US biopharma firms with products in preclinical and early clinical development.
Titel: |
Frontrunners in Molecular Glues.
|
---|---|
Autor/in / Beteiligte Person: | Barton, Cheryl |
Zeitschrift: | Pharmaceutical Technology Europe, Jg. 36 (2024), Heft 1, S. 18-20 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1753-7967 (print) |
Schlagwort: |
|
Sonstiges: |
|